Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen

Abstract

Abstract:Medicinal plant-derived bioactive compounds modulate multiple therapeutic targets in cardiovascular diseases (CVDs), rendering herb-derived phytochemicals effective against one of the major CVDs-atherosclerosis. Danshen (Salvia milthiorriza Bunge) is a Chinese medicine that has been used in cardio-and cerebro-vascular therapeutic remedies in Asian countries for many years. Emerging evidence from cellular, animal, and clinical studies suggests that major lipophilic tanshinones from Danshen can treat atherosclerotic CVDs. In this review, we highlight recent advances in understanding the molecular mechanisms of tanshinones in treating atherosclerosis, ranging from endothelial dysfunction to chronic inflammation. We also overview new molecular targets of tanshinones, including endothelial nitric oxide synthase, AMP-activated protein kinase, ABC transporter A1, heme oxygenase 1, soluble epoxide hydrolase, 11β-hydroxysteroid dehydrogenase, estrogen receptor, and proprotein convertase subtilisin/kexin type 9. Thus, this review provides a new perspective for advancing our understanding of the "ancient" herb Danshen from "modern" biomedical perspectives, supporting the possibility of exploiting tanshinones and derivatives as effective therapeutics against atherosclerosis-related cardiovascular and metabolic diseases.

Endothelial function and dysfunction: Impact of metformin

“…Cardiovascular disease (CVD) is the largest cause of morbidity and mortality in modern societies (Fang, Little, & Xu, 2017;Writing Group, et al, 2016). The major underlying pathology of CVD is atherosclerosis (Libby, 2006;Little, Osman, & O'Brien, 2008;Ross, 1986;Tabas, Williams, & Boren, 2007).…”

Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potential

“…Cardiovascular and cerebrovascular diseases, such as atherosclerosis, hypertension, cardiac hypertrophy, myocardial infarction, heart failure, stroke, and cerebral ischemia are the leading causes of morbidity and mortality in developing and developed countries [1][2][3][4][5][6]. The pathogenesis of these diseases is complex and has not yet been fully elucidated.…”

Tanshinone IIA inhibits lipopolysaccharide‑induced inflammatory responses through the TLR4/TAK1/NF‑κB signaling pathway in vascular smooth muscle cells

“…Tanshinone IIA (Tan IIA) is primarily extracted from the root of Salvia miltiorrhiza Bunge, known as 'danshen' in chinese traditional medicine. For centuries danshen has been used to treat cardiovascular diseases, including coronary heart disease (14). Tan IIA is an important constituent of Tans which are abietane-type norditerpenoid quinone natural products.…”